logo

STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Craig A. Erickson, Jeremy Veenstra-VanderWeele, Raun D. Melmed, James T. McCracken, Linmarie Sikich, Lawrence Scahill, Maryann Cherubini, Peter Zarevics, Karen Walton-Bowen, Randall L. Carpenter, Mark F. Bear, Paul P. Wang, Bryan H. King
Title
STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.
Journal
Journal of Autism and Developmental Disorders
Year
2014
Volume
44
Issue
4
Page(s)
pp. 958-964.
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Peer-Reviewed, Open Trial
Keywords
Adolescent / Secondary School Age, Arbaclofen, Autism, Autistic Disorder, Child/Children, GABA Receptor Agonist, Gamma Aminobutyric Acid, Interaction/Withdrawl, Intervention, Irritability, Lethargy, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Primary / Elementary School Age, Social Skills

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Publications | Publications Database | Search Publications